FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom
The US FDA’s action plan for rare neurodegenerative diseases including ALS, foreshadows steps to improve ALS research and treatment availability.
By
UK News
Latest in
UK News
How close are we to getting a male contraceptive?
With public demand for new options, the male contraceptive research field is advancing despite persistent challenges.
By
Can a nasal spray tackle agitation in autism?
Despite the need, children with autism spectrum disorder are left with few difficult-to-administer off-label medications to treat agitation.
By
CAMP4’s $100m Series B backs regulatory RNA-led efforts in urea cycle disorders
CAMP4 Therapeutics’ $100 million Series B supports clinical trial plans for urea cycle disorder program in 2023.
By
NewAmsterdam Pharma enters merger deal with Frazier Lifesciences
The proceeds from the merger will be used to fund all anticipated milestones for obicetrapib before approval.
Prescribing shift for Pfizer’s Paxlovid expands access but draws questions
A recent US FDA decision expands access by allowing pharmacists to prescribe the oral Covid-19 antiviral but evokes concerns from…
By
California’s low-cost insulin plans receive $100m manufacturing boost
Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, even though most insulin is currently produced…
By
Is biotech facing a long bear market?
As news of layoffs and downsizing across a handful of biotechs continues to come in, the sector may not be…
By